Esthesioneuroblastoma CT

Revision as of 16:01, 13 January 2016 by Simrat Sarai (talk | contribs)
Jump to navigation Jump to search

Esthesioneuroblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esthesioneuroblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esthesioneuroblastoma CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esthesioneuroblastoma CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esthesioneuroblastoma CT

CDC on Esthesioneuroblastoma CT

Esthesioneuroblastoma CT in the news

Blogs on Esthesioneuroblastoma CT

Directions to Hospitals Treating Esthesioneuroblastoma

Risk calculators and risk factors for Esthesioneuroblastoma CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

CT

CT is particularly useful in assessing bony destruction, although it cannot distinguish olfactory neuroblastomas from other tumors that arise in the same region. The mass is of soft tissue attenuation, with relatively homogeneous enhancement 3. Focal calcification are occasionally present 3. These tumors are relatively slow growing and thus, the bony margins are often remodeled and resorbed, rather than being aggressively destroyed

The tumors are slow growing and the choice of imaging will depend on the tumour's size. They begin as masses in the superior olfactory recess and initially involve the anterior and middle ethmoid air-cells on one side1-2. As they grow, they tend to destroy surrounding bone, and can extend in any direction. This invasion may be superiorly into the anterior cranial fossa, laterally into the orbits and across the midline into the contralateral nasal cavity. They can also obstruct the ostia of paranasal sinuses resulting in opacification of the sinus with secretions 2.

Particular attention should be paid to the presence of cervical and retropharyngeal nodal metastases which are present in 10-44% of cases at diagnosis

References

Template:Central nervous system tumors

Template:WH Template:WS